{
    "clinical_study": {
        "@rank": "10006", 
        "arm_group": [
            {
                "arm_group_label": "5g Serum-derived bovine immunoglobulin protein isolate (SBI)", 
                "arm_group_type": "Other", 
                "description": "Phase 1:  Twelve subjects will receive either a 5.0 g total daily dose of SBI on Day 1 followed by 5.0 g Placebo on Day 2 or a 5.0 g total daily dose of Placebo on Day 1 followed by 5.0 g SBI on Day 2 during the double-blind, crossover phase.\nPhase 2:  2.5g SBI will be taken two times a day for 14 days during the open-label phase."
            }, 
            {
                "arm_group_label": "10g Serum-derived bovine immunoglobulin protein isolate (SBI)", 
                "arm_group_type": "Other", 
                "description": "Phase 1:  Twelve subjects will receive either a 10.0 g total daily dose of SBI on Day 1 followed by 10.0 g Placebo on Day 2 or a 10.0 g total daily dose of Placebo on Day 1 followed by 10.0 g SBI on Day 2 during the double-blind, crossover phase.\nPhase 2:   5.0 g SBI will taken two times a day for 14 days during the open-label phase."
            }, 
            {
                "arm_group_label": "20g Serum-derived bovine immunoglobulin protein isolate (SBI)", 
                "arm_group_type": "Other", 
                "description": "Phase 1:  Twelve subjects will receive either a 20.0 g total daily dose of SBI on Day 1 followed by 20.0 g Placebo on Day 2 or a 20.0 g total daily dose of Placebo on Day 1 followed by 20.0 g SBI on Day 2 during the double-blind, crossover phase.\nPhase 2:   20.0 g SBI will be taken two times a day for 14 days during the open-label phase."
            }, 
            {
                "arm_group_label": "Matching Placebo", 
                "arm_group_type": "Other", 
                "description": "Placebo will be taken either on Day 1 or on Day 2 based on the randomization during the double-blind, crossover phase."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the digestibility of serum-derived bovine\n      immunoglobulin protein isolate in healthy adults. The information generated may help\n      elucidate SBI's mechanism of action."
        }, 
        "brief_title": "Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults", 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Body mass index of 18-32\n\n          -  Medically normal with no significant abnormal findings at screening\n\n        Exclusion Criteria:\n\n          -  Allergy or intolerance to beef\n\n          -  Participated in another investigational study within 30 days\n\n          -  Seropostive for HIV, hepatitis B surface antigen, hepatitis C virus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02017405", 
            "org_study_id": "EH4001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "5g Serum-derived bovine immunoglobulin protein isolate (SBI)", 
                    "10g Serum-derived bovine immunoglobulin protein isolate (SBI)", 
                    "20g Serum-derived bovine immunoglobulin protein isolate (SBI)"
                ], 
                "description": "Serum-derived bovine immunoglobulin protein isolate is a specially formulated light-colored protein powder composed of immunoglobulin (IgG) and other serum proteins similar to those found in colostrum and milk. Serum-derived bovine immunoglobulin protein isolate does not contain any milk products such as lactose, casein, or whey. Serum-derived bovine immunoglobulin protein isolate is gluten-free, dye-free, and soy-free. Serum-derived bovine immunoglobulin protein isolate is manufactured in accordance with current Good Manufacturing Practice (cGMP) and FDA guidelines for medical food ingredients.", 
                "intervention_name": "Serum-derived bovine immunoglobulin protein isolate (SBI)", 
                "intervention_type": "Other", 
                "other_name": "EnteraGam\u2122"
            }, 
            {
                "arm_group_label": "Matching Placebo", 
                "intervention_name": "Matching Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Immunoglobulins", 
                "Antibodies"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Digestibility", 
            "Healthy volunteers", 
            "serum-derived bovine immunoglobulin protein isolate", 
            "bovine IgG", 
            "adults"
        ], 
        "lastchanged_date": "March 10, 2014", 
        "link": {
            "description": "EnteraGam\u2122", 
            "url": "http://www.enteragam.com/"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cary", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27518"
                    }, 
                    "name": "PMG Research of Cary"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }, 
                    "name": "Wake Research Associates"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized, Crossover Clinical Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) in Healthy Adults", 
        "other_outcome": {
            "measure": "Incidence of Adverse Events", 
            "safety_issue": "No", 
            "time_frame": "2 weeks"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Amino Acid Metabolism", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02017405"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Bovine IgG Plasma Concentration", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "Bovine IgG Plasma Concentration", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Bovine IgG Concentration in Stool", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }
        ], 
        "source": "Entera Health, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Entera Health, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}